Oral beclometasone dipropionate in the treatment of extensive and left-sided active ulcerative colitis: a multicentre randomised study.
about
Oral corticosteroids for induction of remission in ulcerative colitisGlucose intolerance and diabetes mellitus in ulcerative colitis: pathogenetic and therapeutic implicationsReview article: problematic proctitis and distal colitisEfficacy and Safety of Beclomethasone Dipropionate versus 5-Aminosalicylic Acid in the Treatment of Ulcerative Colitis: A Systematic Review and Meta-AnalysisEuropean evidence-based Consensus on the management of ulcerative colitis: Current management.Current therapy of ulcerative colitis in children.Emerging drugs for the treatment of ulcerative colitisEfficacy and Safety of Oral Beclomethasone Dipropionate in Ulcerative Colitis: A Systematic Review and Meta-Analysis.Steroids and 5-aminosalicylic acids in moderate ulcerative colitis: addressing the dilemma.Treatment of inflammatory bowel disease: a review of medical therapy.Therapeutic strategies for the management of ulcerative colitis.Clinical Efficacy of Beclomethasone Dipropionate in Korean Patients with Ulcerative Colitis.Treatment of steroid-naive ulcerative colitis.Second Korean guidelines for the management of ulcerative colitis.Efficacy and safety of drugs for ulcerative colitis.Optimization of conventional therapy in patients with IBD.Oral locally active steroids in inflammatory bowel disease.Second-generation corticosteroids for the treatment of Crohn's disease and ulcerative colitis: more effective and less side effects?Low bioavailability steroids in inflammatory bowel disease: an old chestnut or a whole new ballgame?"Mucosal healing" in ulcerative colitis: Between clinical evidence and market suggestion.Ulcerative colitis: current pharmacotherapy and future directions.Review article: The pharmacokinetics and pharmacodynamics of drugs used in inflammatory bowel disease treatment.The safety of non-biological treatments in Ulcerative Colitis.Systematic review: second-generation vs. conventional corticosteroids for induction of remission in ulcerative colitis.Defining endoscopic response and remission in ulcerative colitis clinical trials: an international consensus.Safety Considerations with the Use of Corticosteroids and Biologic Therapies in Mild-to-Moderate Ulcerative Colitis.Recent advances in the management of distal ulcerative colitis.Usefulness of oral beclometasone dipropionate in the treatment of active ulcerative colitis in clinical practice: the RECLICU Study.Oral prolonged release beclomethasone dipropionate and prednisone in the treatment of active ulcerative colitis: results from a double-blind, randomized, parallel group study.How do you avoid and treat steroid side effects?Infliximab for the treatment of ulcerative colitis.
P2860
Q24244780-ECDB9CF6-E5CE-4CC8-AB5A-C37EA4CE0580Q26866110-89E05656-ECEE-4951-B049-63CCAEEC8654Q28280774-AA7DEE60-C887-43B0-9A8C-4C4C3912A39AQ28553419-38CE03B8-F30D-4125-86AD-417F89F448EAQ34025054-56B6564C-8439-45DB-9C6C-05CC27A45DF1Q35609674-9032AD22-F7C7-4123-AEAD-D28C9DC5FD11Q36039436-D5A7C474-38AF-4224-9ED6-C2C994D96629Q36193009-E9F986C1-154F-45D7-9413-11CC52B8F490Q36515613-F8715223-5137-4395-BA5A-DBF23759C2D5Q37058862-D572A36D-FD9A-42F1-9514-B5C90BE69392Q37318035-BA03BBB7-EB8A-4E78-B032-33742EDA456DQ37438305-8F904998-F856-49D6-B9E6-E4EACDD7A30DQ37483916-BED8FE53-2554-46C3-89FE-2176B312E226Q37662503-B268D421-DF5C-40C3-8BDE-80B048B787EBQ37727232-DFE6D6C1-BB63-4769-8844-2F0DD85C9AD6Q37942292-BDC29699-38E4-4B15-BBFB-35FE33F4B91DQ38025531-A43ADE02-8E1B-4523-B223-E932B4669198Q38026396-090E570A-04FF-4906-ABEA-2DFE5C987020Q38216510-A4909950-7A11-462E-B191-33E02098FE18Q38217234-2CD50FF9-D31B-42D5-A847-E4D324D1B651Q38217653-1BCF3540-2FC6-4931-B6AF-FC34E978FB6CQ38501680-8693B2F8-8FF6-4C2D-AE6A-3CF3DE1AFAECQ38728164-B7E3DD27-D83B-4529-B510-57666BB4F3F0Q38960072-9EE63DD2-64A1-49FD-9860-4B18EFE59E30Q39098635-3ADB3FAB-5E0B-47C7-9B9A-572A5E212BA4Q40046590-D59CC3E5-AA90-472B-9E46-819009B00FACQ42730491-2B136573-C135-4245-A42E-3C607ACF630EQ42788626-275EE860-1123-4C64-BFA4-082A562C209BQ44755570-DCEEE804-B1CE-4612-907E-B4C177948F86Q46347476-7A29CDBD-516B-44A8-8E1B-1F7385730B94Q47682064-5EF95D45-1D14-41D2-B7BA-60D8D22CD476
P2860
Oral beclometasone dipropionate in the treatment of extensive and left-sided active ulcerative colitis: a multicentre randomised study.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Oral beclometasone dipropionat ...... multicentre randomised study.
@en
Oral beclometasone dipropionat ...... multicentre randomised study.
@nl
type
label
Oral beclometasone dipropionat ...... multicentre randomised study.
@en
Oral beclometasone dipropionat ...... multicentre randomised study.
@nl
prefLabel
Oral beclometasone dipropionat ...... multicentre randomised study.
@en
Oral beclometasone dipropionat ...... multicentre randomised study.
@nl
P2093
P2860
P50
P1476
Oral beclometasone dipropionat ...... a multicentre randomised study
@en
P2093
A D'Arienzo
D Valpiani
G D'Albasio
G N Castiglione
M Pitzalis
P2860
P304
P356
10.1046/J.1365-2036.2003.01609.X
P407
P577
2003-06-01T00:00:00Z